What Is the Future of Single Channel Infusion Connector Market? 2026–2034 According to a newly published market research report by 24LifeSciences, global Single Channel Needleless Infusion Connector market was valued at USD 797 million in 2024 and is projected to reach USD 1.18 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2025–2031. Single channel needleless infusion connectors represent a critical advancement in intravenous therapy safety, designed specifically to eliminate needlestick injuries while maintaining the integrity of closed medication delivery systems. These devices feature sophisticated sealing mechanisms that prevent microbial contamination when not actively in use, significantly reducing the incidence of catheter-related bloodstream infections which impact hundreds of thousands of patients globally each year. The technology has become particularly vital in high-risk clinical environments including oncology departments, intensive care units, and long-term therapeutic settings where frequent vascular access is necessary for patient care. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4946/single-channel-needleless-infusion-connector-market

Sodium Chloride Injection for Safe IV Medication Dilution Many antibiotics, analgesics, and chemotherapy agents require dilution in sodium chloride injection before administration. Its neutral pH and isotonic nature prevent drug precipitation and vein irritation. Pharmacies and hospitals use sterile 0.9% sodium chloride injection as the universal diluent for intravenous compatibility. Read More : https://bacteriostaticwaterusa.com/products/bacteriostatic-sodium-chloride-30ml-x-1-qty-vial